UCL Great Ormond Street Institute of Child Health, University College London, London, UK.
Leeds School of Medicine, University of Leeds, Leeds, UK.
Childs Nerv Syst. 2021 Nov;37(11):3385-3396. doi: 10.1007/s00381-021-05226-4. Epub 2021 Jun 19.
This retrospective cohort study aimed to investigate the surgical and neurodevelopmental outcomes (NDO) of infant hydrocephalus. We also sought to determine whether these outcomes are disproportionately poorer in post-haemorrhagic hydrocephalus (PHH) compared to other causes of infant hydrocephalus.
A review of all infants with hydrocephalus who had ventriculoperitoneal (VP) shunts inserted at Great Ormond Street Hospital (GOSH) from 2008 to 2018 was performed. Demographic, surgical, neurodevelopmental, and other clinical data extracted from electronic patient notes were analysed by aetiology. Shunt survival, NDO, cerebral palsy (CP), epilepsy, speech delay, education, behavioural disorders, endocrine dysfunction, and mortality were evaluated.
A total of 323 infants with median gestational age of 37.0 (23.29-42.14) weeks and birthweight of 2640 g (525-4684 g) were evaluated. PHH was the most common aetiology (31.9%) and was associated with significantly higher 5-year shunt revision rates, revisions beyond a year, and median number of revisions than congenital or "other" hydrocephalus (all p < 0.02). Cox regression demonstrated poorest shunt survival in PHH, related to gestational age at birth and corrected age at shunt insertion. PHH also had the highest rate of severe disabilities, increasing with age to 65.0% at 10 years, as well as the highest CP rate; only genetic hydrocephalus had significantly higher endocrine dysfunction (p = 0.01) and mortality rates (p = 0.04).
Infants with PHH have poorer surgical and NDO compared to all other aetiologies, except genetic hydrocephalus. Research into measures of reducing neurodisability following PHH is urgently required. Long-term follow-up is essential to optimise support and outcomes.
本回顾性队列研究旨在探讨婴儿脑积水的手术和神经发育结局(NDO)。我们还试图确定与其他类型婴儿脑积水相比,这些结局在出血后脑积水(PHH)中是否更差。
对 2008 年至 2018 年期间在大奥蒙德街医院(GOSH)接受脑室腹腔分流术(VP)的所有脑积水婴儿进行了回顾性研究。从电子病历中提取人口统计学、手术、神经发育和其他临床数据,并按病因进行分析。评估分流管生存、NDO、脑瘫(CP)、癫痫、言语延迟、教育、行为障碍、内分泌功能障碍和死亡率。
共评估了 323 名中位胎龄为 37.0(23.29-42.14)周、出生体重为 2640g(525-4684g)的婴儿。PHH 是最常见的病因(31.9%),与先天性或“其他”脑积水相比,5 年分流管再手术率、1 年后的再手术率和中位数的再手术次数明显更高(均 p < 0.02)。Cox 回归分析显示,PHH 的分流管存活率最差,与出生时的胎龄和分流管插入时的矫正年龄有关。PHH 还具有最高的严重残疾发生率,随着年龄的增长,10 岁时达到 65.0%,CP 发生率也最高;只有遗传性脑积水的内分泌功能障碍(p = 0.01)和死亡率(p = 0.04)明显更高。
与所有其他病因相比,PHH 婴儿的手术和 NDO 较差,但除了遗传性脑积水。迫切需要研究减少 PHH 后神经残疾的措施。长期随访对于优化支持和结局至关重要。